Literature DB >> 19651258

IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.

Masako Yoshimatsu1, Hideki Kitaura, Yuji Fujimura, Toshiko Eguchi, Haruka Kohara, Yukiko Morita, Noriaki Yoshida.   

Abstract

It has been reported that TNF-alpha plays an important role in bone resorption in pathological conditions. IL-12, which is a T cell mediator, is also an important inflammatory cytokine. We previously reported that IL-12 induces apoptosis in bone marrow cells treated with TNF-alpha in vitro via an interaction between TNF-alpha-induced Fas and IL-12-induced Fas ligand (FasL), and that, as a result, osteoclastogenesis is inhibited. The purpose of this study was to investigate the effects of IL-12 on TNF-alpha-mediated osteoclastogenesis in vivo. We administered TNF-alpha with and without IL-12 into the supracalvaria in mice. The numbers of osteoclasts in the sutures in the calvaria were higher in mice administered TNF-alpha than in control mice not administered TNF-alpha. The numbers of osteoclasts in mice administered both TNF-alpha and IL-12 were lower than those in mice administered only TNF-alpha. Next, we determined the levels of mRNAs for cathepsin K and tartrate-resistant acid phosphatase (TRAP). mRNA levels were increased in mice administered TNF-alpha compared with control mice, but not in mice administered both TNF-alpha and IL-12. We also evaluated the amounts of tartrate-resistant acid phosphatase 5b (TRACP 5b) in mouse sera. The levels of TRACP 5b in mice administered TNF-alpha were higher than those in control mice. On the other hand, in mice administered both TNF-alpha and IL-12, the levels were lower than those in mice administered TNF-alpha alone. Fas and FasL expression levels were analyzed by real-time RT-PCR. The levels of Fas mRNA were increased in the calvaria of mice administered TNF-alpha compared with control mice, while those of FasL mRNAs were increased in the calvaria of mice administered IL-12. In TdT-mediated dUTP-biotin nick end-labeling (TUNEL) assays, many apoptotic cells were found in the sutures in the calvaria of mice administered both TNF-alpha and IL-12. IL-12 also inhibited TNF-alpha-induced osteoclastogenesis in mice whose T cells were blocked by anti-CD4 and anti-CD8 antibodies. These results suggest that IL-12 inhibits TNF-alpha-mediated osteoclastogenesis and induces apoptotic changes through an interaction between TNF-alpha-induced Fas and IL-12-induced FasL, in vivo, via a T cell-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651258     DOI: 10.1016/j.bone.2009.07.079

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  19 in total

1.  Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litivn
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 2.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

3.  Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women.

Authors:  Satish Bharadwaj; Tezus A G Naidu; Guru V Betageri; Nemani V Prasadarao; A Satyanarayan Naidu
Journal:  Inflamm Res       Date:  2010-05-15       Impact factor: 4.575

4.  The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-α-induced bone resorption lacunae on mouse calvariae.

Authors:  Kenichi Nagano; Neil Alles; Anower Hussain Mian; Asako Shimoda; Nobuyuki Morimoto; Yukihiko Tamura; Hitoyata Shimokawa; Kazunari Akiyoshi; Keiichi Ohya; Kazuhiro Aoki
Journal:  J Bone Miner Metab       Date:  2011-06-01       Impact factor: 2.626

Review 5.  Targeting Fas in osteoresorptive disorders.

Authors:  Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Ana Marusic
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

6.  Effects of anti-mouse RANKL antibody on orthodontic tooth movement in mice.

Authors:  Masako Yoshimatsu; Hideki Kitaura; Yukiko Morita; Takuya Nakamura; Takashi Ukai
Journal:  J Dent Sci       Date:  2022-02-28       Impact factor: 3.719

7.  Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.

Authors:  Ilaria Roato; Francesco Porta; Alessandro Mussa; Lucia D'Amico; Ludovica Fiore; Davide Garelli; Marco Spada; Riccardo Ferracini
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

8.  Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis.

Authors:  Niki M Moutsopoulos; Heather M Kling; Nikola Angelov; Wenwen Jin; Robert J Palmer; Salvador Nares; Manuel Osorio; Sharon M Wahl
Journal:  J Autoimmun       Date:  2012-05-03       Impact factor: 7.094

9.  An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast.

Authors:  Zhiyuan Feng; Yuqin Shen; Liying Wang; Lin Cheng; Jing Wang; Quanshun Li; Wei Shi; Xinhua Sun
Journal:  Int J Mol Sci       Date:  2011-04-15       Impact factor: 5.923

Review 10.  Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.

Authors:  Hideki Kitaura; Keisuke Kimura; Masahiko Ishida; Haruka Kohara; Masako Yoshimatsu; Teruko Takano-Yamamoto
Journal:  Clin Dev Immunol       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.